TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Net margin 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) net profit margin by fiscal year — reported net income divided by reported revenue.
8.2%FY2025 · since FY2016: 1.5% → 8.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.2% | +18.1 pp |
| FY2024 | -9.9% | -6.4 pp |
| FY2023 | -3.5% | +12.9 pp |
| FY2022 | -16.4% | -19.0 pp |
| FY2021 | 2.6% | +26.6 pp |
| FY2020 | -24.0% | -18.0 pp |
| FY2019 | -5.9% | +5.9 pp |
| FY2018 | -11.8% | +62.7 pp |
| FY2017 | -74.4% | -75.9 pp |
| FY2016 | 1.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice